No Data
No Data
No Data
No Data
No Data
Scopus BioPharma's Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer
DUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma Data Suggests Benefits of Combinations of DUET-102 with Other T-Cell Based Immunotherapies, such as
GlobeNewswireNov 7, 2023 22:15
Scopus BioPharma's Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (OTCQB: "SCPS"), a biotechnology company developing transformational therapeutics for serious diseases with significant unmet medical need, and its
GlobeNewswireNov 2, 2023 21:15
Nasdaq to Delist Shares of Waitr and Calithera Biosciences, Among Others
Seeking AlphaMar 2, 2023 07:26
Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of EQONEX LIMITED. EQONEX LIMITED ordinary shares were suspended on November 30, 2022, and
GlobeNewswireMar 2, 2023 05:12
Scopus BioPharma (NASDAQ:SCPS) Shares Down 8.3%
Shares of Scopus BioPharma Inc. (NASDAQ:SCPS – Get Rating) dropped 8.3% on Wednesday . The company traded as low as $0.10 and last traded at $0.11. Approximately 21,957 shares traded hands during mid
Defense WorldJan 19, 2023 14:41
Scopus BioPharma Inc. (NASDAQ:SCPS) Sees Significant Increase in Short Interest
Scopus BioPharma Inc. (NASDAQ:SCPS – Get Rating) was the recipient of a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 60,400 share
Financial News LiveDec 29, 2022 07:41
No Data
No Data